Free Trial
→ Elon Reveals Why There Soon Won’t Be Any Money For Social Security (From Colonial Metals) (Ad) Buy MXL Stock  Free MXL Stock Alerts

MaxLinear (MXL) Financials

MaxLinear logo
$10.43 +0.53 (+5.35%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$10.20 -0.23 (-2.24%)
As of 04/15/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for MaxLinear

Annual Income Statements for MaxLinear

This table shows MaxLinear's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -7.04 -42 61 -9.19 -26 -20 -99 42 125 -73 -245
Consolidated Net Income / (Loss)		 -7.04 -20 61 -9.19 -26 -20 -99 42 125 -73 -245
Net Income / (Loss) Continuing Operations		 -7.04 -20 61 -9.19 -26 -20 -99 42 125 -73 -245
Total Pre-Tax Income 		-8.75 -43 64 -34 -33 -32 -115 48 174 -64 -239
Total Operating Income		 -8.86 -44 63 -22 -19 -22 -101 65 180 -38 -223
Total Gross Profit		 82 155 230 208 209 168 213 496 650 386 195
Total Revenue		 133 300 388 420 385 317 479 892 1,120 693 361
Operating Revenue		 133 300 388 420 385 317 479 892 1,120 693 361
Total Cost of Revenue		 51 145 158 212 176 149 266 397 470 308 166
Operating Cost of Revenue		 51 145 158 212 176 149 266 397 470 308 166
Total Operating Expenses		 91 199 167 230 228 190 314 431 470 424 418
Selling, General & Admin Expense		 34 78 64 106 102 89 130 150 168 132 138
Research & Development Expense		 57 85 98 112 120 98 180 278 296 270 225
Impairment Charge		 0.00 0.00 1.30 2.00 2.20 0.00 0.09 0.00 2.81 2.44 1.24
Restructuring Charge		 0.00 14 3.43 9.52 3.84 2.64 3.83 2.20 2.27 20 53
Total Other Income / (Expense), net		 0.11 1.49 0.63 -12 -14 -10 -14 -17 -6.05 -26 -15
Interest Expense		 - 0.10 0.10 10 14 11 13 18 9.77 11 11
Interest & Investment Income		 0.24 0.28 0.57 0.27 0.08 0.78 0.41 0.08 0.25 6.05 6.39
Other Income / (Expense), net		 -0.12 1.31 0.16 -2.22 0.42 -0.07 -1.17 0.76 3.48 -21 -11
Income Tax Expense		 -1.70 -0.58 2.40 -25 -6.65 -13 -16 5.90 49 9.34 6.48
Basic Earnings per Share		 ($0.19) ($0.79) $0.96 ($0.14) ($0.38) ($0.28) ($1.35) $0.55 $1.60 ($0.91) ($2.93)
Weighted Average Basic Shares Outstanding		 36.47M 53.38M 63.78M 66.25M 68.49M 71.01M 73.13M 76.04M 78.04M 80.72M 83.60M
Diluted Earnings per Share		 ($0.19) ($0.79) $0.91 ($0.14) ($0.38) ($0.28) ($1.35) $0.53 $1.55 ($0.91) ($2.93)
Weighted Average Diluted Shares Outstanding		 36.47M 53.38M 67.65M 66.25M 68.49M 71.01M 73.13M 79.68M 80.85M 80.72M 83.60M
Weighted Average Basic & Diluted Shares Outstanding		 37.10M 53.60M 63.80M 65.60M 71.95M 71.95M 74.54M 76.78M 78.75M 81.93M 84.63M

Quarterly Income Statements for MaxLinear

This table shows MaxLinear's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 28 31 9.53 -4.35 -40 -39 -72 -39 -76 -58
Consolidated Net Income / (Loss)		 28 31 9.53 -4.35 -40 -39 -72 -39 -76 -58
Net Income / (Loss) Continuing Operations		 28 31 9.53 -4.35 -40 -39 -72 -39 -76 -58
Total Pre-Tax Income 		45 41 25 -4.76 -42 -43 -74 -41 -82 -41
Total Operating Income		 52 41 27 -5.94 -18 -42 -75 -41 -67 -41
Total Gross Profit		 167 163 140 103 74 69 49 50 44 51
Total Revenue		 286 291 248 184 136 125 95 92 81 92
Operating Revenue		 286 291 248 184 136 125 95 92 81 92
Total Cost of Revenue		 118 127 108 81 62 57 46 42 37 41
Operating Cost of Revenue		 118 127 108 81 62 57 46 42 37 41
Total Operating Expenses		 116 122 113 109 92 110 124 91 111 92
Selling, General & Admin Expense		 38 44 39 34 25 34 36 34 30 38
Research & Development Expense		 76 74 67 71 66 65 65 57 53 51
Restructuring Charge		 0.63 1.17 4.65 4.44 0.05 11 23 0.87 27 3.06
Total Other Income / (Expense), net		 -7.35 -0.45 -2.18 1.18 -24 -0.89 0.55 -0.51 -16 0.35
Interest Expense		 2.71 2.29 2.49 2.59 2.72 2.91 2.71 2.71 2.66 2.80
Interest & Investment Income		 0.06 0.07 0.63 1.90 1.74 1.78 1.82 1.87 1.65 1.04
Other Income / (Expense), net		 -4.71 1.77 -0.32 1.87 -23 0.24 1.43 0.33 -15 2.11
Income Tax Expense		 16 9.63 16 -0.41 -1.69 -4.13 -1.76 -2.06 -6.71 17
Basic Earnings per Share		 $0.36 $0.39 $0.12 ($0.05) ($0.49) ($0.49) ($0.88) ($0.47) ($0.90) ($0.68)
Weighted Average Basic Shares Outstanding		 78.44M 78.04M 79.47M 80.45M 81.25M 80.72M 82.35M 83.48M 84.07M 83.60M
Diluted Earnings per Share		 $0.35 $0.38 $0.12 ($0.05) ($0.49) ($0.49) ($0.88) ($0.47) ($0.90) ($0.68)
Weighted Average Diluted Shares Outstanding		 80.06M 80.85M 81.34M 80.45M 81.25M 80.72M 82.35M 83.48M 84.07M 83.60M
Weighted Average Basic & Diluted Shares Outstanding		 78.57M 78.75M 79.98M 81.02M 81.56M 81.93M 83.13M 83.90M 84.36M 84.63M

Annual Cash Flow Statements for MaxLinear

This table details how cash moves in and out of MaxLinear's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -5.75 47 15 -8.48 -0.22 19 57 -18 57 -0.00 -69
Net Cash From Operating Activities		 12 55 117 75 103 78 74 168 389 43 -45
Net Cash From Continuing Operating Activities		 12 55 117 75 103 78 74 168 389 43 -45
Net Income / (Loss) Continuing Operations		 -7.04 -42 61 -9.19 -26 -20 -99 42 125 -73 -245
Consolidated Net Income / (Loss)		 -7.04 -42 61 -9.19 -26 -20 -99 42 125 -73 -245
Depreciation Expense		 5.11 41 27 67 79 66 77 92 81 72 54
Amortization Expense		 0.72 15 5.81 26 1.15 1.58 2.20 3.00 1.98 2.56 2.54
Non-Cash Adjustments To Reconcile Net Income		 15 50 15 27 32 24 77 59 71 62 79
Changes in Operating Assets and Liabilities, net		 -1.59 -7.94 8.16 -36 17 6.32 16 -28 109 -20 65
Net Cash From Investing Activities		 -17 -11 -101 -432 -7.83 -6.97 -175 -92 -92 -16 -23
Net Cash From Continuing Investing Activities		 -17 -11 -101 -432 -7.83 -6.97 -175 -92 -92 -16 -23
Purchase of Property, Plant & Equipment		 -8.80 -3.00 -8.51 -7.47 -7.83 -6.89 -12 -39 -41 -13 -18
Acquisitions		 -9.14 -3.72 -101 -479 0.00 -0.09 -163 -48 -11 -20 -5.77
Purchase of Investments		 -57 -73 -90 -31 0.00 0.00 0.00 -5.00 -29 0.00 0.00
Sale and/or Maturity of Investments		 57 69 99 85 0.00 - - 0.00 0.00 17 0.00
Other Investing Activities, net		 - - - - - - 0.00 0.00 -10 0.00 0.00
Net Cash From Financing Activities		 -0.51 4.00 -0.67 347 -94 -53 160 -92 -240 -26 1.29
Net Cash From Continuing Financing Activities		 -0.51 4.00 -0.67 347 -94 -53 160 -92 -240 -26 1.29
Repayment of Debt		 - 0.00 0.00 -70 -93 -50 -20 -414 -185 -18 0.00
Repurchase of Common Equity		 0.00 -0.81 -0.00 -0.33 0.00 0.00 0.00 -24 -32 0.00 0.00
Issuance of Common Equity		 3.30 9.95 6.65 12 6.84 8.60 8.07 8.78 5.01 4.56 4.09
Other Financing Activities, net		 -3.81 -5.14 -7.32 -12 -7.62 -12 -3.54 -13 -29 -13 -2.81
Effect of Exchange Rate Changes		 -0.02 -0.73 -0.39 1.58 -1.30 0.93 -1.04 -2.87 0.06 -1.08 -1.30
Cash Interest Paid		 - 0.00 0.00 8.84 14 11 11 11 9.08 9.48 9.74
Cash Income Taxes Paid		 0.19 0.04 1.58 9.44 5.43 4.42 2.82 3.84 24 29 8.19

Quarterly Cash Flow Statements for MaxLinear

This table details how cash moves in and out of MaxLinear's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 -30 5.86 20 17 -37 0.20 4.57 -6.79 -37 -30
Net Cash From Operating Activities		 62 69 42 31 -13 -17 16 -2.70 -31 -28
Net Cash From Continuing Operating Activities		 62 69 42 31 -13 -17 16 -2.70 -31 -28
Net Income / (Loss) Continuing Operations		 28 31 9.53 -4.35 -40 -39 -72 -39 -76 -58
Consolidated Net Income / (Loss)		 28 31 9.53 -4.35 -40 -39 -72 -39 -76 -58
Depreciation Expense		 18 19 19 19 17 17 17 14 12 12
Amortization Expense		 0.51 0.51 0.55 0.63 0.69 0.70 0.69 0.67 0.64 0.55
Non-Cash Adjustments To Reconcile Net Income		 22 33 16 19 1.87 25 19 9.80 27 22
Changes in Operating Assets and Liabilities, net		 -7.20 -14 -2.66 -3.89 7.47 -21 52 13 4.84 -4.34
Net Cash From Investing Activities		 -15 -17 -16 -13 -2.60 15 -8.71 -5.79 -5.95 -3.00
Net Cash From Continuing Investing Activities		 -15 -17 -16 -13 -2.60 15 -8.71 -5.79 -5.95 -3.00
Purchase of Property, Plant & Equipment		 -9.12 -17 -5.22 -5.04 -1.93 -1.27 -8.34 -3.01 -4.13 -2.19
Acquisitions		 -5.24 -0.74 -10 -7.61 -0.67 -1.10 -0.37 -2.78 -1.82 -0.81
Net Cash From Financing Activities		 -75 -49 -6.17 0.11 -21 1.17 -2.10 2.03 -0.06 1.42
Net Cash From Continuing Financing Activities		 -75 -49 -6.17 0.11 -21 1.17 -2.10 2.03 -0.06 1.42
Issuance of Common Equity		 0.08 1.79 0.00 3.07 0.09 1.39 0.00 1.58 - 2.51
Other Financing Activities, net		 -0.38 -0.37 -6.17 -2.97 -3.23 -0.22 -2.10 0.45 -0.06 -1.09
Effect of Exchange Rate Changes		 -1.04 2.46 0.00 -1.23 -0.63 0.78 -0.58 -0.34 0.09 -0.47
Cash Interest Paid		 2.64 2.16 2.16 2.34 2.48 2.50 2.48 2.47 2.49 2.30
Cash Income Taxes Paid		 4.61 9.75 3.34 11 11 3.31 1.36 2.06 6.05 -1.28

Annual Balance Sheets for MaxLinear

This table presents MaxLinear's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 136 335 423 825 744 706 1,022 1,050 1,180 1,080 865
Total Current Assets		 101 190 213 201 185 182 362 404 563 488 323
Cash & Equivalents		 21 68 81 72 73 93 149 131 187 187 119
Restricted Cash		 - - 0.61 1.48 0.65 0.35 0.12 0.11 0.98 1.05 1.00
Accounts Receivable		 19 42 50 66 59 50 67 120 171 171 85
Inventories, net		 11 32 27 53 42 32 98 132 161 100 90
Prepaid Expenses		 2.44 3.90 6.16 8.42 10 6.79 47 22 25 29 28
Plant, Property, & Equipment, net		 12 22 21 23 18 17 39 61 79 66 59
Total Noncurrent Assets		 25 123 189 601 540 507 621 585 538 526 482
Goodwill		 1.20 50 76 238 238 238 303 307 307 319 319
Intangible Assets		 13 51 104 315 245 188 207 153 109 74 55
Noncurrent Deferred & Refundable Income Taxes		 - - 0.12 40 52 67 86 89 66 69 69
Other Noncurrent Operating Assets		 0.51 2.27 1.68 6.92 4.66 14 24 36 55 64 40
Other Noncurrent Nonoperating Assets		 - - 1.20 1.06 0.40 0.06 1.02 1.06 0.02 0.02 0.03
Total Liabilities & Shareholders' Equity		 136 335 423 825 744 706 1,022 1,050 1,180 1,080 865
Total Liabilities		 37 72 70 437 344 291 631 561 504 394 348
Total Current Liabilities		 33 56 55 76 75 67 234 207 341 222 182
Accounts Payable		 7.51 6.39 6.76 17 16 13 33 53 69 22 31
Accrued Expenses		 16 35 32 42 45 44 154 98 213 170 131
Current Employee Benefit Liabilities		 6.56 9.98 10 13 15 9.39 47 57 59 30 20
Total Noncurrent Liabilities		 3.36 16 16 361 268 224 398 354 163 172 166
Long-Term Debt		 - - 0.00 348 256 207 364 306 122 122 123
Other Noncurrent Operating Liabilities		 1.19 4.32 6.03 8.56 13 17 34 48 41 49 43
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 99 263 352 387 400 415 391 489 676 686 516
Total Preferred & Common Equity		 99 263 352 387 400 415 391 489 676 686 516
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 99 263 352 387 400 415 391 489 676 686 516
Common Stock		 178 385 414 456 493 530 602 657 723 809 887
Retained Earnings		 -79 -121 -60 -69 -94 -114 -212 -170 -45 -119 -364
Accumulated Other Comprehensive Income / (Loss)		 -0.03 -0.82 -1.56 1.04 0.27 -0.89 1.44 2.13 -1.02 -3.79 -6.82

Quarterly Balance Sheets for MaxLinear

This table presents MaxLinear's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets		 1,183 1,198 1,161 1,104 1,031 973 895
Total Current Assets		 563 594 554 509 445 398 328
Cash & Equivalents		 181 208 225 187 192 185 148
Restricted Cash		 0.97 0.96 1.04 1.11 1.03 1.01 0.99
Accounts Receivable		 178 189 156 158 126 85 48
Inventories, net		 166 150 126 115 96 95 96
Prepaid Expenses		 18 28 26 33 29 32 35
Plant, Property, & Equipment, net		 67 78 74 69 68 65 63
Total Noncurrent Assets		 553 527 533 526 518 510 504
Goodwill		 307 319 318 318 319 319 319
Intangible Assets		 122 96 91 83 65 62 58
Noncurrent Deferred & Refundable Income Taxes		 66 58 57 59 72 74 83
Other Noncurrent Operating Assets		 58 54 67 65 62 56 44
Other Noncurrent Nonoperating Assets		 0.03 0.02 0.02 0.02 0.02 0.02 0.02
Total Liabilities & Shareholders' Equity		 1,183 1,198 1,161 1,104 1,031 973 895
Total Liabilities		 567 464 415 401 393 356 338
Total Current Liabilities		 351 300 242 233 224 190 169
Accounts Payable		 91 55 46 45 32 36 31
Accrued Expenses		 211 217 171 158 163 133 116
Current Employee Benefit Liabilities		 49 29 25 30 28 22 22
Total Noncurrent Liabilities		 215 164 174 168 169 166 170
Long-Term Debt		 172 122 122 122 123 123 123
Other Noncurrent Operating Liabilities		 44 42 52 46 46 43 47
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 616 734 746 703 638 617 557
Total Preferred & Common Equity		 616 734 746 703 638 617 557
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 616 734 746 703 638 617 557
Common Stock		 698 771 789 791 834 854 867
Retained Earnings		 -76 -36 -40 -80 -191 -230 -306
Accumulated Other Comprehensive Income / (Loss)		 -5.32 -1.21 -2.29 -7.94 -5.57 -6.52 -3.85

Annual Metrics and Ratios for MaxLinear

This table displays calculated financial ratios and metrics derived from MaxLinear's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.25% 125.64% 29.12% 8.38% -8.40% -17.61% 50.89% 86.46% 25.53% -38.12% -48.00%
EBITDA Growth		 59.94% 515.90% 630.75% -27.82% -11.00% -25.44% -151.46% 781.50% 65.69% -94.40% -1,290.34%
EBIT Growth		 28.46% -371.42% 249.33% -137.79% 21.84% -18.48% -362.39% 164.52% 178.33% -132.20% -295.92%
NOPAT Growth		 28.28% -392.76% 298.61% -125.00% 11.88% -15.50% -358.53% 180.80% 126.18% -120.68% -484.37%
Net Income Growth		 44.70% -183.88% 406.64% -114.99% -185.17% 24.05% -395.49% 142.57% 197.93% -158.50% -235.21%
EPS Growth		 48.65% -315.79% 215.19% -115.38% -171.43% 26.32% -382.14% 139.26% 192.45% -158.71% -221.98%
Operating Cash Flow Growth		 -5.09% 349.90% 113.14% -36.02% 36.80% -23.70% -6.07% 128.60% 131.06% -88.84% -204.43%
Free Cash Flow Firm Growth		 -379.59% -388.00% 83.94% -1,944.46% 114.29% -43.19% -492.93% 98.82% 11,721.82% -127.65% 0.08%
Invested Capital Growth		 7,036.56% 479.87% 62.82% 206.38% -11.98% -9.08% 14.37% 9.75% -10.90% 4.91% -16.22%
Revenue Q/Q Growth		 0.68% 28.42% -2.96% 6.75% -6.35% -5.26% 35.24% 6.34% 3.96% -19.25% -8.43%
EBITDA Q/Q Growth		 -62.79% 59.17% 21.92% 7.04% -19.45% -1.03% -63.33% 53.89% 2.56% -85.29% -1.48%
EBIT Q/Q Growth		 -26.99% -8.11% 34.74% -168.93% -27.46% 8.51% -18.24% 502.44% 7.04% -334.05% 1.03%
NOPAT Q/Q Growth		 -26.83% -10.59% 38.42% -182.06% -35.91% 11.21% -18.42% 566.92% 1.87% -227.90% 0.25%
Net Income Q/Q Growth		 3.89% 44.71% -8.17% -149.37% 42.99% -73.28% -20.20% 485.78% 2.38% -1,950.66% -8.56%
EPS Q/Q Growth		 5.00% -8.22% 37.88% -151.85% 42.42% -64.71% -20.54% 431.25% 1.97% -2,175.00% -6.93%
Operating Cash Flow Q/Q Growth		 -41.25% 122.70% 2.66% -7.24% 2.42% 5.29% 168.28% -25.71% 15.90% -66.46% -33.10%
Free Cash Flow Firm Q/Q Growth		 -434.10% 24.35% 9.55% 1.42% -23.02% 57.05% 17.95% -102.55% 31.33% -27.12% 14.03%
Invested Capital Q/Q Growth		 978.74% -17.10% -5.62% -4.24% -2.21% -4.47% -10.09% 8.25% 0.83% -0.30% -1.99%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 61.57% 51.75% 59.30% 49.48% 54.23% 52.87% 44.46% 55.56% 58.00% 55.63% 54.03%
EBITDA Margin		 -2.37% 4.36% 24.68% 16.44% 15.97% 14.46% -4.93% 18.02% 23.78% 2.15% -49.25%
Operating Margin		 -6.65% -14.53% 16.26% -5.16% -4.96% -6.95% -21.13% 7.31% 16.09% -5.51% -61.95%
EBIT Margin		 -6.75% -14.10% 16.30% -5.68% -4.85% -6.98% -21.38% 7.40% 16.40% -8.53% -64.97%
Profit (Net Income) Margin		 -5.29% -6.65% 15.80% -2.19% -6.81% -6.27% -20.60% 4.70% 11.16% -10.55% -68.01%
Tax Burden Percent		 80.51% 46.59% 96.23% 27.02% 79.75% 61.25% 85.84% 87.67% 71.78% 114.63% 102.71%
Interest Burden Percent		 97.37% 101.34% 100.74% 142.29% 175.91% 146.81% 112.26% 72.52% 94.82% 107.86% 101.92%
Effective Tax Rate		 0.00% 0.00% 3.77% 0.00% 0.00% 0.00% 0.00% 12.33% 28.22% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -53.55% -39.36% 34.87% -3.46% -2.15% -2.78% -12.49% 9.02% 20.62% -4.42% -27.43%
ROIC Less NNEP Spread (ROIC-NNEP)		 -52.52% -49.58% 34.42% 5.31% -7.80% -5.80% -29.48% 1.17% 10.90% 56.99% 256.50%
Return on Net Nonoperating Assets (RNNOA)		 45.97% 28.32% -14.95% 0.98% -4.50% -2.10% -11.97% 0.51% 0.84% -6.32% -13.35%
Return on Equity (ROE)		 -7.58% -11.04% 19.92% -2.48% -6.65% -4.88% -24.46% 9.54% 21.46% -10.74% -40.78%
Cash Return on Invested Capital (CROIC)		 -248.03% -180.52% -12.93% -105.03% 10.59% 6.73% -25.90% -0.27% 32.15% -9.21% -9.78%
Operating Return on Assets (OROA)		 -6.89% -18.01% 16.70% -3.83% -2.38% -3.05% -11.84% 6.37% 16.47% -5.23% -24.09%
Return on Assets (ROA)		 -5.40% -8.50% 16.19% -1.47% -3.34% -2.75% -11.41% 4.05% 11.21% -6.47% -25.21%
Return on Common Equity (ROCE)		 -7.58% -11.04% 19.92% -2.48% -6.65% -4.88% -24.46% 9.54% 21.46% -10.74% -40.78%
Return on Equity Simple (ROE_SIMPLE)		 -7.10% -7.60% 17.39% -2.37% -6.55% -4.80% -25.21% 8.58% 18.49% -10.66% -47.49%
Net Operating Profit after Tax (NOPAT)		 -6.20 -31 61 -15 -13 -15 -71 57 129 -27 -156
NOPAT Margin		 -4.66% -10.17% 15.65% -3.61% -3.47% -4.87% -14.79% 6.41% 11.55% -3.86% -43.37%
Net Nonoperating Expense Percent (NNEP)		 -1.03% 10.22% 0.45% -8.77% 5.64% 3.02% 16.98% 7.85% 9.72% -61.40% -283.93%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 16.21% -3.31% -24.46%
Cost of Revenue to Revenue		 38.43% 48.25% 40.70% 50.52% 45.77% 47.13% 55.54% 44.44% 42.00% 44.37% 45.97%
SG&A Expenses to Revenue		 25.69% 25.96% 16.62% 25.18% 26.44% 27.98% 27.17% 16.80% 15.00% 19.06% 38.37%
R&D to Revenue		 42.54% 28.43% 25.20% 26.71% 31.18% 31.01% 37.61% 31.20% 26.46% 38.87% 62.46%
Operating Expenses to Revenue		 68.23% 66.28% 43.04% 54.63% 59.19% 59.82% 65.60% 48.25% 41.91% 61.14% 115.98%
Earnings before Interest and Taxes (EBIT)		 -8.98 -42 63 -24 -19 -22 -102 66 184 -59 -234
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.15 13 96 69 62 46 -24 161 266 15 -178
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.79 3.45 3.99 4.57 3.03 3.66 7.24 11.83 3.94 2.83 3.23
Price to Tangible Book Value (P/TBV)		 3.27 5.61 8.17 0.00 0.00 0.00 0.00 192.90 10.25 6.59 11.69
Price to Revenue (P/Rev)		 2.08 3.02 3.63 4.21 3.15 4.79 5.92 6.48 2.38 2.80 4.63
Price to Earnings (P/E)		 0.00 0.00 22.95 0.00 0.00 0.00 0.00 137.84 21.33 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 4.36% 0.00% 0.00% 0.00% 0.00% 0.73% 4.69% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 8.62 5.86 5.90 3.09 2.40 3.09 5.04 8.98 4.37 3.02 3.22
Enterprise Value to Revenue (EV/Rev)		 1.48 2.59 3.28 4.86 3.63 5.15 6.37 6.68 2.31 2.70 4.64
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 59.28 13.28 29.57 22.70 35.60 0.00 37.07 9.69 125.55 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 20.11 0.00 0.00 0.00 0.00 90.30 14.06 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 20.95 0.00 0.00 0.00 0.00 104.20 19.96 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.09 14.11 10.84 27.22 13.59 20.84 41.40 35.43 6.64 43.18 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 21.23 43.71 0.00 0.00 12.80 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.90 0.64 0.50 0.93 0.63 0.18 0.18 0.24
Long-Term Debt to Equity		 0.00 0.00 0.00 0.90 0.64 0.50 0.93 0.63 0.18 0.18 0.24
Financial Leverage		 -0.88 -0.57 -0.43 0.18 0.58 0.36 0.41 0.44 0.08 -0.11 -0.05
Leverage Ratio		 1.40 1.30 1.23 1.69 1.99 1.78 2.14 2.35 1.91 1.66 1.62
Compound Leverage Factor		 1.37 1.32 1.24 2.40 3.50 2.61 2.41 1.71 1.81 1.79 1.65
Debt to Total Capital		 0.00% 0.00% 0.00% 47.29% 39.01% 33.27% 48.18% 38.49% 15.26% 15.13% 19.24%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 47.29% 39.01% 33.27% 48.18% 38.49% 15.26% 15.13% 19.24%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 52.71% 60.99% 66.73% 51.82% 61.51% 84.74% 84.87% 80.76%
Debt to EBITDA		 0.00 0.00 0.00 5.03 4.16 4.51 -15.41 1.90 0.46 8.20 -0.69
Net Debt to EBITDA		 0.00 0.00 0.00 3.97 2.96 2.48 -9.09 1.09 -0.32 -4.42 -0.02
Long-Term Debt to EBITDA		 0.00 0.00 0.00 5.03 4.16 4.51 -15.41 1.90 0.46 8.20 -0.69
Debt to NOPAT		 0.00 0.00 0.00 -22.91 -19.13 -13.40 -5.14 5.35 0.94 -4.57 -0.79
Net Debt to NOPAT		 0.00 0.00 0.00 -18.08 -13.61 -7.37 -3.03 3.07 -0.66 2.47 -0.02
Long-Term Debt to NOPAT		 0.00 0.00 0.00 -22.91 -19.13 -13.40 -5.14 5.35 0.94 -4.57 -0.79
Altman Z-Score		 5.07 8.06 13.68 2.90 2.56 3.45 2.69 7.24 4.81 3.56 2.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.04 3.40 3.90 2.64 2.46 2.73 1.55 1.95 1.65 2.20 1.77
Quick Ratio		 2.64 2.75 3.29 1.81 1.76 2.15 0.93 1.21 1.10 1.61 1.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -29 -140 -23 -460 66 37 -147 -1.74 202 -56 -56
Operating Cash Flow to CapEx		 139.02% 1,837.15% 1,378.25% 1,009.20% 1,312.32% 1,137.62% 589.36% 429.43% 942.30% 322.37% -256.19%
Free Cash Flow to Firm to Interest Expense		 0.00 -1,401.43 -216.43 -44.34 4.61 3.35 -11.33 -0.10 20.65 -5.21 -5.13
Operating Cash Flow to Interest Expense		 0.00 550.41 1,128.05 7.23 7.20 7.04 5.68 9.23 39.80 4.05 -4.17
Operating Cash Flow Less CapEx to Interest Expense		 0.00 520.45 1,046.20 6.52 6.65 6.42 4.72 7.08 35.57 2.80 -5.79
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.02 1.28 1.02 0.67 0.49 0.44 0.55 0.86 1.00 0.61 0.37
Accounts Receivable Turnover		 6.90 9.86 8.35 7.21 6.13 5.77 8.12 9.54 7.71 4.06 2.82
Inventory Turnover		 4.90 6.69 5.35 5.31 3.70 4.08 4.11 3.46 3.22 2.36 1.74
Fixed Asset Turnover		 14.83 17.51 18.29 19.46 18.75 18.12 17.07 17.78 16.01 9.53 5.73
Accounts Payable Turnover		 6.81 20.86 24.01 17.92 10.84 10.30 11.51 9.25 7.74 6.83 6.26
Days Sales Outstanding (DSO)		 52.90 37.02 43.71 50.62 59.53 63.24 44.94 38.28 47.36 89.92 129.63
Days Inventory Outstanding (DIO)		 74.53 54.52 68.25 68.77 98.56 89.42 88.81 105.64 113.36 154.53 209.48
Days Payable Outstanding (DPO)		 53.57 17.50 15.20 20.36 33.69 35.44 31.72 39.45 47.15 53.47 58.28
Cash Conversion Cycle (CCC)		 73.85 74.04 96.76 99.02 124.41 117.22 102.04 104.46 113.57 190.98 280.83
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 23 132 216 661 582 529 605 664 591 620 520
Invested Capital Turnover		 11.50 3.87 2.23 0.96 0.62 0.57 0.84 1.41 1.79 1.14 0.63
Increase / (Decrease) in Invested Capital		 23 110 83 445 -79 -53 76 59 -72 29 -101
Enterprise Value (EV)		 197 777 1,271 2,043 1,396 1,632 3,047 5,961 2,582 1,873 1,672
Market Capitalization		 276 907 1,407 1,769 1,214 1,519 2,832 5,785 2,667 1,939 1,669
Book Value per Share		 $2.66 $4.27 $5.46 $5.79 $5.80 $5.80 $5.27 $6.38 $8.61 $8.41 $6.12
Tangible Book Value per Share		 $2.27 $2.63 $2.67 ($2.47) ($1.21) ($0.16) ($1.60) $0.39 $3.31 $3.61 $1.69
Total Capital		 99 263 352 735 656 622 755 795 798 809 639
Total Debt		 0.00 0.00 0.00 348 256 207 364 306 122 122 123
Total Long-Term Debt		 0.00 0.00 0.00 348 256 207 364 306 122 122 123
Net Debt		 -79 -130 -136 274 182 114 215 175 -85 -66 3.42
Capital Expenditures (CapEx)		 8.80 3.00 8.51 7.44 7.83 6.89 12 39 41 13 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.43 23 29 52 36 22 -21 66 15 78 22
Debt-free Net Working Capital (DFNWC)		 68 134 158 125 110 115 128 197 222 266 141
Net Working Capital (NWC)		 68 134 158 125 110 115 128 197 222 266 141
Net Nonoperating Expense (NNE)		 0.84 -11 -0.61 -5.98 13 4.46 28 15 4.34 46 89
Net Nonoperating Obligations (NNO)		 -76 -130 -137 273 182 114 214 174 -85 -66 3.39
Total Depreciation and Amortization (D&A)		 5.83 55 33 93 80 68 79 95 83 74 57
Debt-free, Cash-free Net Working Capital to Revenue		 -1.07% 7.63% 7.40% 12.27% 9.42% 6.98% -4.38% 7.40% 1.35% 11.19% 5.99%
Debt-free Net Working Capital to Revenue		 50.84% 44.67% 40.82% 29.72% 28.58% 36.32% 26.76% 22.04% 19.82% 38.35% 39.15%
Net Working Capital to Revenue		 50.84% 44.67% 40.82% 29.72% 28.58% 36.32% 26.76% 22.04% 19.82% 38.35% 39.15%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.19) ($0.79) $0.96 ($0.14) ($0.38) ($0.28) ($1.35) $0.55 $1.60 ($0.91) ($2.93)
Adjusted Weighted Average Basic Shares Outstanding		 36.47M 53.38M 63.78M 66.25M 68.49M 71.01M 73.13M 76.04M 78.04M 80.72M 83.60M
Adjusted Diluted Earnings per Share		 ($0.19) ($0.79) $0.91 ($0.14) ($0.38) ($0.28) ($1.35) $0.53 $1.55 ($0.91) ($2.93)
Adjusted Weighted Average Diluted Shares Outstanding		 36.47M 53.38M 67.65M 66.25M 68.49M 71.01M 73.13M 79.68M 80.85M 80.72M 83.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 37.97M 62.42M 65.11M 67.41M 69.56M 71.95M 74.54M 76.78M 78.75M 81.93M 84.63M
Normalized Net Operating Profit after Tax (NOPAT)		 -6.20 -21 65 -7.10 -9.14 -14 -68 59 133 -11 -118
Normalized NOPAT Margin		 -4.66% -6.89% 16.82% -1.69% -2.37% -4.29% -14.22% 6.63% 11.87% -1.62% -32.76%
Pre Tax Income Margin		 -6.57% -14.28% 16.42% -8.09% -8.53% -10.24% -24.00% 5.36% 15.55% -9.20% -66.21%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 -423.38 607.90 -2.30 -1.31 -1.99 -7.90 3.62 18.81 -5.53 -21.54
NOPAT to Interest Expense		 0.00 -305.54 583.51 -1.46 -0.94 -1.39 -5.47 3.14 13.25 -2.50 -14.38
EBIT Less CapEx to Interest Expense		 0.00 -453.34 526.06 -3.02 -1.86 -2.61 -8.86 1.47 14.59 -6.79 -23.17
NOPAT Less CapEx to Interest Expense		 0.00 -335.50 501.66 -2.18 -1.49 -2.01 -6.43 0.99 9.02 -3.76 -16.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -4.03% 0.00% -3.64% 0.00% 0.00% 0.00% 56.11% 25.20% 0.00% 0.00%

Quarterly Metrics and Ratios for MaxLinear

This table displays calculated financial ratios and metrics derived from MaxLinear's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 24.35% 17.22% -5.87% -34.31% -52.57% -56.86% -61.65% -49.99% -40.16% -26.47%
EBITDA Growth		 39.94% 11.97% -34.88% -76.96% -134.50% -138.87% -219.50% -271.86% -200.86% -10.70%
EBIT Growth		 99.50% 39.19% -43.09% -108.82% -185.81% -196.66% -371.52% -894.38% -101.03% 5.89%
NOPAT Growth		 216.48% 8.26% -71.13% -114.62% -137.69% -192.99% -604.15% -587.55% -274.58% 1.37%
Net Income Growth		 206.85% 10.31% -71.62% -113.61% -240.20% -223.87% -858.51% -802.46% -90.28% -50.23%
EPS Growth		 191.67% 8.57% -71.43% -112.50% -240.00% -228.95% -833.33% -840.00% -83.67% -38.78%
Operating Cash Flow Growth		 -26.54% 332.59% -68.58% -75.23% -120.71% -123.90% -62.12% -108.82% -140.24% -67.97%
Free Cash Flow Firm Growth		 -14.67% 446.93% 182.24% -147.91% -180.73% -156.13% -64.80% 185.41% 193.77% 223.24%
Invested Capital Growth		 -4.34% -10.90% -2.23% 7.28% 6.09% 4.91% -9.69% -10.96% -14.77% -16.22%
Revenue Q/Q Growth		 2.04% 1.70% -14.50% -25.96% -26.32% -7.51% -24.00% -3.44% -11.84% 13.64%
EBITDA Q/Q Growth		 -0.03% -5.94% -25.00% -67.33% -249.67% -5.99% -130.55% 53.01% -162.02% 61.00%
EBIT Q/Q Growth		 2.29% -9.12% -37.22% -115.11% -895.56% -2.38% -76.33% 44.67% -101.27% 52.07%
NOPAT Q/Q Growth		 16.38% -5.05% -67.03% -140.11% -200.12% -134.27% -78.75% 45.29% -63.51% 38.31%
Net Income Q/Q Growth		 -11.13% 9.41% -69.33% -145.64% -815.40% 3.34% -87.82% 45.70% -93.00% 23.68%
EPS Q/Q Growth		 -12.50% 8.57% -68.42% -141.67% -880.00% 0.00% -79.59% 46.59% -91.49% 24.44%
Operating Cash Flow Q/Q Growth		 -49.96% 12.29% -39.21% -27.47% -141.83% -29.56% 196.36% -116.88% -1,039.87% 9.41%
Free Cash Flow Firm Q/Q Growth		 -38.32% 73.83% -76.20% -287.78% -3.93% -20.86% 114.92% 355.65% 14.11% 58.85%
Invested Capital Q/Q Growth		 1.15% 0.83% 6.30% -1.04% 0.02% -0.30% -8.50% -2.43% -4.26% -1.99%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 58.62% 56.21% 56.47% 55.93% 54.56% 54.68% 51.71% 54.56% 54.35% 55.60%
EBITDA Margin		 23.17% 21.43% 18.80% 8.30% -16.85% -19.31% -58.58% -28.51% -84.73% -29.08%
Operating Margin		 18.18% 14.16% 10.98% -3.23% -13.15% -33.30% -78.32% -44.37% -82.30% -44.67%
EBIT Margin		 16.53% 14.78% 10.85% -2.21% -29.91% -33.11% -76.82% -44.02% -100.49% -42.38%
Profit (Net Income) Margin		 9.94% 10.70% 3.84% -2.37% -29.39% -30.71% -75.90% -42.69% -93.44% -62.75%
Tax Burden Percent		 63.70% 76.34% 37.98% 91.41% 95.93% 90.31% 97.62% 95.02% 91.86% 141.68%
Interest Burden Percent		 94.39% 94.82% 93.12% 116.90% 102.42% 102.72% 101.21% 102.06% 101.23% 104.51%
Effective Tax Rate		 36.30% 23.66% 62.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 20.81% 19.31% 7.25% -3.79% -13.07% -26.68% -49.51% -23.68% -39.36% -19.78%
ROIC Less NNEP Spread (ROIC-NNEP)		 13.37% 18.54% -10.38% -3.45% 36.66% -14.39% -26.70% -12.27% 14.86% 72.94%
Return on Net Nonoperating Assets (RNNOA)		 1.57% 1.42% -0.08% 0.30% -3.06% 1.60% 3.42% 1.69% -1.27% -3.80%
Return on Equity (ROE)		 22.38% 20.73% 7.17% -3.49% -16.13% -25.08% -46.09% -21.99% -40.63% -23.58%
Cash Return on Invested Capital (CROIC)		 25.61% 32.15% 18.67% 4.63% -7.26% -9.21% -6.21% -9.24% -11.25% -9.78%
Operating Return on Assets (OROA)		 15.93% 14.84% 10.43% -1.91% -22.46% -20.31% -37.22% -18.48% -39.58% -15.71%
Return on Assets (ROA)		 9.58% 10.74% 3.69% -2.04% -22.07% -18.84% -36.78% -17.92% -36.81% -23.27%
Return on Common Equity (ROCE)		 22.38% 20.73% 7.17% -3.49% -16.13% -25.08% -46.09% -21.99% -40.63% -23.58%
Return on Equity Simple (ROE_SIMPLE)		 19.83% 0.00% 13.76% 8.67% -0.51% 0.00% -24.29% -30.77% -40.56% 0.00%
Net Operating Profit after Tax (NOPAT)		 33 31 10 -4.16 -12 -29 -52 -29 -47 -29
NOPAT Margin		 11.58% 10.81% 4.17% -2.26% -9.20% -23.31% -54.83% -31.06% -57.61% -31.27%
Net Nonoperating Expense Percent (NNEP)		 7.44% 0.77% 17.63% -0.34% -49.73% -12.28% -22.81% -11.40% -54.23% -92.72%
Return On Investment Capital (ROIC_SIMPLE)		 - 3.94% - - - -3.61% - - - -4.51%
Cost of Revenue to Revenue		 41.38% 43.79% 43.53% 44.07% 45.44% 45.32% 48.29% 45.44% 45.65% 44.40%
SG&A Expenses to Revenue		 13.46% 15.30% 15.56% 18.33% 18.74% 27.43% 38.30% 36.53% 37.18% 41.32%
R&D to Revenue		 26.75% 25.37% 27.09% 38.41% 48.92% 52.05% 67.98% 61.46% 64.86% 55.64%
Operating Expenses to Revenue		 40.44% 42.05% 45.50% 59.16% 67.71% 87.98% 130.04% 98.93% 136.65% 100.28%
Earnings before Interest and Taxes (EBIT)		 47 43 27 -4.07 -41 -42 -73 -40 -81 -39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 66 62 47 15 -23 -24 -56 -26 -69 -27
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 4.15 3.94 3.78 3.38 2.57 2.83 2.39 2.71 2.18 3.23
Price to Tangible Book Value (P/TBV)		 13.66 10.25 8.70 7.50 5.98 6.59 5.98 7.07 6.74 11.69
Price to Revenue (P/Rev)		 2.37 2.38 2.51 2.50 2.10 2.80 2.82 3.74 3.09 4.63
Price to Earnings (P/E)		 20.92 21.33 27.46 39.03 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.78% 4.69% 3.64% 2.56% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.31 4.37 4.24 3.86 2.77 3.02 2.56 2.91 2.24 3.22
Enterprise Value to Revenue (EV/Rev)		 2.34 2.31 2.41 2.38 2.01 2.70 2.69 3.59 3.02 4.64
Enterprise Value to EBITDA (EV/EBITDA)		 9.72 9.69 11.05 12.60 16.98 125.55 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 14.72 14.06 16.33 21.23 68.13 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 19.89 19.96 25.56 34.26 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.53 6.64 8.99 11.77 13.32 43.18 84.52 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 16.44 12.80 22.47 86.20 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.28 0.18 0.17 0.16 0.17 0.18 0.19 0.20 0.22 0.24
Long-Term Debt to Equity		 0.28 0.18 0.17 0.16 0.17 0.18 0.19 0.20 0.22 0.24
Financial Leverage		 0.12 0.08 0.01 -0.09 -0.08 -0.11 -0.13 -0.14 -0.09 -0.05
Leverage Ratio		 2.08 1.91 1.82 1.78 1.73 1.66 1.62 1.57 1.59 1.62
Compound Leverage Factor		 1.97 1.81 1.70 2.08 1.78 1.70 1.64 1.60 1.61 1.69
Debt to Total Capital		 21.79% 15.26% 14.24% 14.06% 14.82% 15.13% 16.11% 16.58% 18.07% 19.24%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 21.79% 15.26% 14.24% 14.06% 14.82% 15.13% 16.11% 16.58% 18.07% 19.24%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 78.21% 84.74% 85.76% 85.94% 85.18% 84.87% 83.89% 83.42% 81.93% 80.76%
Debt to EBITDA		 0.66 0.46 0.51 0.64 1.21 8.20 -1.40 -0.95 -0.70 -0.69
Net Debt to EBITDA		 -0.11 -0.32 -0.44 -0.65 -0.79 -4.42 0.80 0.49 0.15 -0.02
Long-Term Debt to EBITDA		 0.66 0.46 0.51 0.64 1.21 8.20 -1.40 -0.95 -0.70 -0.69
Debt to NOPAT		 1.35 0.94 1.17 1.74 -14.98 -4.57 -1.25 -1.00 -0.78 -0.79
Net Debt to NOPAT		 -0.23 -0.66 -1.01 -1.77 9.87 2.47 0.72 0.52 0.17 -0.02
Long-Term Debt to NOPAT		 1.35 0.94 1.17 1.74 -14.98 -4.57 -1.25 -1.00 -0.78 -0.79
Altman Z-Score		 3.87 4.42 4.83 4.78 3.55 3.61 2.61 3.07 2.03 2.75
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.60 1.65 1.98 2.29 2.18 2.20 1.99 2.09 1.95 1.77
Quick Ratio		 1.08 1.10 1.38 1.66 1.55 1.61 1.42 1.42 1.16 1.12
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 60 104 25 -46 -48 -58 8.69 40 45 72
Operating Cash Flow to CapEx		 677.33% 417.11% 808.26% 607.07% -663.83% -1,300.86% 191.44% -89.48% -743.73% -1,269.40%
Free Cash Flow to Firm to Interest Expense		 22.02 45.28 9.93 -17.90 -17.75 -20.02 3.21 14.64 17.02 25.62
Operating Cash Flow to Interest Expense		 22.78 30.26 16.95 11.80 -4.71 -5.70 5.89 -1.00 -11.57 -9.94
Operating Cash Flow Less CapEx to Interest Expense		 19.42 23.01 14.85 9.86 -5.42 -6.14 2.81 -2.11 -13.13 -10.72
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.96 1.00 0.96 0.86 0.75 0.61 0.48 0.42 0.39 0.37
Accounts Receivable Turnover		 7.56 7.71 7.03 6.89 5.11 4.06 3.43 3.72 3.82 2.82
Inventory Turnover		 3.06 3.22 3.25 3.19 2.69 2.36 2.00 1.87 1.72 1.74
Fixed Asset Turnover		 17.94 16.01 16.04 14.62 12.57 9.53 7.40 6.44 5.92 5.73
Accounts Payable Turnover		 5.82 7.74 8.18 7.30 5.56 6.83 5.64 5.06 4.79 6.26
Days Sales Outstanding (DSO)		 48.26 47.36 51.94 52.99 71.49 89.92 106.43 98.05 95.56 129.63
Days Inventory Outstanding (DIO)		 119.13 113.36 112.24 114.44 135.61 154.53 182.68 195.50 212.00 209.48
Days Payable Outstanding (DPO)		 62.74 47.15 44.64 49.98 65.68 53.47 64.66 72.16 76.19 58.28
Cash Conversion Cycle (CCC)		 104.65 113.57 119.54 117.46 141.43 190.98 224.45 221.39 231.38 280.83
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 586 591 629 622 622 620 568 554 530 520
Invested Capital Turnover		 1.80 1.79 1.74 1.68 1.42 1.14 0.90 0.76 0.68 0.63
Increase / (Decrease) in Invested Capital		 -27 -72 -14 42 36 29 -61 -68 -92 -101
Enterprise Value (EV)		 2,526 2,582 2,667 2,400 1,722 1,873 1,452 1,611 1,188 1,672
Market Capitalization		 2,555 2,667 2,773 2,524 1,803 1,939 1,523 1,674 1,215 1,669
Book Value per Share		 $7.86 $8.61 $9.32 $9.33 $8.67 $8.41 $7.75 $7.43 $6.64 $6.12
Tangible Book Value per Share		 $2.39 $3.31 $4.05 $4.21 $3.72 $3.61 $3.09 $2.85 $2.15 $1.69
Total Capital		 787 798 856 868 825 809 761 740 680 639
Total Debt		 172 122 122 122 122 122 123 123 123 123
Total Long-Term Debt		 172 122 122 122 122 122 123 123 123 123
Net Debt		 -29 -85 -106 -124 -81 -66 -70 -63 -27 3.42
Capital Expenditures (CapEx)		 9.12 17 5.22 5.04 1.93 1.27 8.34 3.01 4.13 2.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 11 15 66 67 73 78 28 21 10 22
Debt-free Net Working Capital (DFNWC)		 212 222 293 313 276 266 221 207 160 141
Net Working Capital (NWC)		 212 222 293 313 276 266 221 207 160 141
Net Nonoperating Expense (NNE)		 4.68 0.34 0.83 0.20 27 9.28 20 11 29 29
Net Nonoperating Obligations (NNO)		 -29 -85 -106 -124 -81 -66 -70 -63 -27 3.39
Total Depreciation and Amortization (D&A)		 19 19 20 19 18 17 17 14 13 12
Debt-free, Cash-free Net Working Capital to Revenue		 0.98% 1.35% 5.97% 6.61% 8.50% 11.19% 5.17% 4.73% 2.59% 5.99%
Debt-free Net Working Capital to Revenue		 19.64% 19.82% 26.56% 31.01% 32.11% 38.35% 40.89% 46.26% 40.55% 39.15%
Net Working Capital to Revenue		 19.64% 19.82% 26.56% 31.01% 32.11% 38.35% 40.89% 46.26% 40.55% 39.15%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.36 $0.39 $0.12 ($0.05) ($0.49) ($0.49) ($0.88) ($0.47) ($0.90) ($0.68)
Adjusted Weighted Average Basic Shares Outstanding		 78.44M 78.04M 79.47M 80.45M 81.25M 80.72M 82.35M 83.48M 84.07M 83.60M
Adjusted Diluted Earnings per Share		 $0.35 $0.38 $0.12 ($0.05) ($0.49) ($0.49) ($0.88) ($0.47) ($0.90) ($0.68)
Adjusted Weighted Average Diluted Shares Outstanding		 80.06M 80.85M 81.34M 80.45M 81.25M 80.72M 82.35M 83.48M 84.07M 83.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 78.57M 78.75M 79.98M 81.02M 81.56M 81.93M 83.13M 83.90M 84.36M 84.63M
Normalized Net Operating Profit after Tax (NOPAT)		 33 34 24 -1.05 -12 -22 -36 -28 -27 -27
Normalized NOPAT Margin		 11.72% 11.86% 9.68% -0.57% -9.17% -17.36% -38.20% -30.40% -33.38% -28.95%
Pre Tax Income Margin		 15.61% 14.01% 10.10% -2.59% -30.63% -34.01% -77.75% -44.92% -101.72% -44.29%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 17.43 18.73 10.84 -1.57 -14.93 -14.27 -26.99 -14.96 -30.70 -13.94
NOPAT to Interest Expense		 12.21 13.71 4.17 -1.60 -4.59 -10.04 -19.27 -10.56 -17.60 -10.29
EBIT Less CapEx to Interest Expense		 14.06 11.48 8.74 -3.52 -15.64 -14.71 -30.07 -16.08 -32.25 -14.72
NOPAT Less CapEx to Interest Expense		 8.84 6.45 2.07 -3.55 -5.30 -10.48 -22.34 -11.67 -19.15 -11.07
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 38.41% 25.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About MaxLinear's Financials

When does MaxLinear's financial year end?

According to the most recent income statement we have on file, MaxLinear's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MaxLinear's net income changed over the last 10 years?

MaxLinear's net income appears to be on an upward trend, with a most recent value of -$245.20 million in 2024, rising from -$7.04 million in 2014. The previous period was -$73.15 million in 2023.

What is MaxLinear's operating income?
MaxLinear's total operating income in 2024 was -$223.35 million, based on the following breakdown:
  • Total Gross Profit: $194.78 million
  • Total Operating Expenses: $418.13 million
How has MaxLinear revenue changed over the last 10 years?

Over the last 10 years, MaxLinear's total revenue changed from $133.11 million in 2014 to $360.53 million in 2024, a change of 170.8%.

How much debt does MaxLinear have?

MaxLinear's total liabilities were at $348.36 million at the end of 2024, a 11.6% decrease from 2023, and a 851.6% increase since 2014.

How much cash does MaxLinear have?

In the past 10 years, MaxLinear's cash and equivalents has ranged from $20.70 million in 2014 to $187.35 million in 2022, and is currently $118.58 million as of their latest financial filing in 2024.

How has MaxLinear's book value per share changed over the last 10 years?

Over the last 10 years, MaxLinear's book value per share changed from 2.66 in 2014 to 6.12 in 2024, a change of 130.2%.

Remove Ads

Related Companies

This page (NASDAQ:MXL) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners
Two Unmistakable Patterns Return…
The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...
Golden Portfolio | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Is it CRAZY to still want reliable profits, despite this market?
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Tariffs. Volatility. Fear. Here’s the Plan.
Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...
Investors Alley | Sponsored
This story is about to go viral
This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...
Stansberry Research | Sponsored
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored